The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

That was before the spectacular success of Hemlibra, a bispecific antibody-based drug that mimics the function of Factor VIII by bridging clotting factors on either side of it in the clotting pathway.

People with haemophilia A have a shortage of a clotting agent called Factor VIII, while people with haemophilia B do not have enough Factor IX. In the 1970s, a new treatment using donated human ...

Thus, although the reduced production of most clotting factors in patients ... coupled with increased von Willebrand factor and factor VIII levels, increases the risk of coagulopathy.

Sam Smith explores how more than a thousand haemophiliacs in the UK acquired HIV through their treatment - in what's come to be known as the contaminated blood scandal.

Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

Zwitterions sound like a distant cousin of Twitter (X), but in fact they are a common macromolecule found in human cells.

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

When Henry VII died in 1509, this popular eighteen-year-old prince, known for his love of hunting and dancing, became King Henry VIII. Soon after he obtained the papal dispensation required to ...

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

Teachers, first responders, medical workers, active military, and veterans can get 55% off your their first box, free shipping, and 15% off all other boxes over the next year.